AI IntelligenceFeb 13, 2026Secondary Market
Article
IOBT
IO Biotech, Inc. filed an SEC 8-K form containing a notice of delisting or failure to satisfy a continued listing rule or standard (Item 3.01). This indicates potential issues with exchange listing requirements for the company.
Data Cube AI EditorialSource: SEC EDGAR
01
Source Brief
IO Biotech, Inc. filed an SEC 8-K form containing a notice of delisting or failure to satisfy a continued listing rule or standard (Item 3.01). This indicates potential issues with exchange listing requirements for the company.
02